Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Sell

C

Enovis Corporation (ENOV)

Orthopedic, Prosthetic & Surgical Appliances & Supplies

https://www.enovis.com

Enovis Corp is a medical technology company focused on developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows by manufacturing and distributing high-quality medical devices with a broad range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy.. The company conducts its operations through two operating segments: Prevention & Recovery ("P&R") and Reconstructive ("Recon"). It generates majority revenue form Prevention & Recovery segment.

2711 CENTERVILLE ROAD, SUITE 400
WILMINGTON, DE

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

05/08/2008

Market Cap

2,495,958,845

Shares Outstanding

54,590,000

Weighted SO

54,594,143

Total Employees

N/A

Upcoming Earnings

08/01/2024

Similar Tickers

HLIO --.--%

NPO --.--%

OFLX --.--%

LXFR --.--%

HURC --.--%

IEX --.--%

WTS --.--%

DCI --.--%

GRC --.--%

Beta

2.0060

Last Div

0.0000

Range

39.98-65.03

Chg

0.2300

Avg Vol

666456

Mkt Cap

2495958845

Exch

NYSE

Country

US

Phone

302 252 9190

DCF Diff

52.2044

DCF

-7.7444

Div Yield

0.0000

P/S

1.3041

EV Multiple

28.3489

P/FV

0.7460

Div Yield %

0.0000

P/E

-27.0729

PEG

-1.9222

Payout

0.0000

Current Ratio

2.2640

Quick Ratio

1.0767

Cash Ratio

0.0676

DSO

75.2774

DIO

260.7990

Op Cycle

336.0764

DPO

67.7748

CCC

268.3016

Gross Margin

0.5503

Op Margin

-0.0409

Pretax Margin

-0.0650

Net Margin

-0.0473

Eff Tax Rate

0.2760

ROA

-0.0166

ROE

-0.0269

ROCE

-0.0159

NI/EBT

0.7277

EBT/EBIT

1.5913

EBIT/Rev

-0.0409

Debt Ratio

0.2511

D/E

0.4159

LT Debt/Cap

0.2880

Total Debt/Cap

0.2937

Int Coverage

-1.6643

CF/Debt

0.0520

Equity Multi

1.6559

Rec Turnover

4.8487

Pay Turnover

5.3855

Inv Turnover

1.3995

FA Turnover

4.2848

Asset Turnover

0.3517

OCF/Share

1.2951

FCF/Share

-1.0986

Cash/Share

0.6381

OCF/Sales

0.0371

FCF/OCF

-0.8482

CF Coverage

0.0520

ST Coverage

1.9035

CapEx Coverage

0.5411

Div&CapEx Cov

0.5411

P/BV

0.7460

P/B

0.7460

P/S

1.3041

P/E

-27.0729

P/FCF

-41.4178

P/OCF

34.5064

P/CF

34.5064

PEG

-1.9222

P/S

1.3041

EV Multiple

28.3489

P/FV

0.7460

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jan 03, 13:26 Enovis schließt Übernahme von LimaCorporate S.p.A. ab GlobeNewswire Inc. Jan 03, 13:26 의료기술 기업Enovis, LimaCorporate 인수 완료 GlobeNewswire Inc. Jan 03, 13:26 Enovis 完成對 LimaCorporate S.p.A 的收購 GlobeNewswire Inc. Jan 03, 13:26 エノビス (Enovis) がリマ・コーポレート (LimaCorporate S.p.A) の買収を完了 GlobeNewswire Inc. Jan 03, 13:26 Enovis 完成对 LimaCorporate S.p.A 的收购 GlobeNewswire Inc. Jan 03, 13:26 Enovis Conclui Aquisição da LimaCorporate S.p.A GlobeNewswire Inc. Jan 03, 13:26 Enovis finalise l’acquisition de LimaCorporate S.p.A. GlobeNewswire Inc. Jan 03, 13:26 Enovis משלימה את רכישת LimaCorporate S.p.A GlobeNewswire Inc. Jan 03, 13:26 Enovis cierra adquisición de LimaCorporate S.p.A GlobeNewswire Inc. Jan 03, 13:26 Enovis Selesaikan Pemerolehan LimaCorporate S.p.A Benzinga Dec 15, 14:38 This Analyst Selects Enovis As Top Pick For 2024: Spotlight On EMPOWR Revision Launch Benzinga Dec 15, 14:38 This Analyst Selects Enovis As Top Pick For 2024: Spotlight On EMPOWR Revision Launch GlobeNewswire Inc. Nov 16, 16:15 Enovis to participate in the 6th Annual EverCore ISI HealthCONx Conference

Revenue Product Segmentation